SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 72 filers reported holding SERES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,670,000 | -11.7% | 220,000 | 0.0% | 0.06% | -17.8% |
| Q2 2018 | $1,892,000 | +17.2% | 220,000 | 0.0% | 0.07% | +5.8% |
| Q1 2018 | $1,615,000 | -27.6% | 220,000 | 0.0% | 0.07% | -31.7% |
| Q4 2017 | $2,231,000 | -36.8% | 220,000 | 0.0% | 0.10% | -38.0% |
| Q3 2017 | $3,529,000 | +42.0% | 220,000 | 0.0% | 0.16% | +29.4% |
| Q2 2017 | $2,486,000 | +0.3% | 220,000 | 0.0% | 0.13% | -11.9% |
| Q1 2017 | $2,479,000 | +13.8% | 220,000 | 0.0% | 0.14% | -2.1% |
| Q4 2016 | $2,178,000 | -19.5% | 220,000 | 0.0% | 0.15% | -14.1% |
| Q3 2016 | $2,704,000 | -64.5% | 220,000 | -16.0% | 0.17% | -69.8% |
| Q2 2016 | $7,611,000 | +9.4% | 262,000 | 0.0% | 0.56% | -3.4% |
| Q1 2016 | $6,959,000 | -19.2% | 262,000 | +6.8% | 0.58% | -10.6% |
| Q4 2015 | $8,611,000 | +61.4% | 245,400 | +36.3% | 0.65% | +50.6% |
| Q3 2015 | $5,335,000 | -38.0% | 180,000 | -13.1% | 0.43% | -31.1% |
| Q2 2015 | $8,599,000 | – | 207,215 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |